Furthermore, lncRNA BLACAT1 activates autophagy through the miR-17/ATG7 pathway, which significantly improves the survival rate of NSCLC cells treated with cisplatin [134]. This evidence concerns the gene BLACAT1 and non-small cell lung carcinoma.